ZVRA
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Zevra Therapeutics published four-year real-world data for MIPLYFFA in Niemann-Pick disease type CAug 3, 2026
- Zevra Therapeutics provides update on EU regulatory submission for arimoclomol in Niemann-Pick disease type CJul 24, 2026
- Zevra reported publication of positive pediatric substudy data for MIPLYFFA in Niemann-Pick disease type CJun 23, 2026
- GeneDx launched a genetic testing program with Zevra Therapeutics to support patients suspected of Niemann-Pick disease type CMar 10, 2026
- Zevra executes distribution agreement to expand MIPLYFFA® access for Niemann-Pick disease type CDec 29, 2025